MIRACLE comprises a consortium of academics and industry partners to understand how machine learning can be utilised to predict the risk of relapse for patients with resected non-small cell lung cancer. The project includes six work packages, this contract focusing on “WP5: Development of the Machine Learning Model”. WP5 requires DFKI to build a bespoke machine learning model for predicting risk of NSCLC relapse – in particular this should include identifying and testing the potential of deep learning survival models.
Partners
Universität Leipzig
